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reduced salt intake
Sodium reduction is enticing, 
but what is the full recipe?
Reading the study of the long term 
effects of dietary sodium reduction on a 
Friday evening, I wondered whether it 
could help my hypertensive patients on 
Monday morning.1 Unfortunately not: the 
prescription for sodium reduction is not 
usable by my fellow general practitioners: 
“Individual and weekly group counselling 
sessions were offered initially, with less 
intensive counselling and support thereafter, 
specific to sodium reduction.”
How do I translate this vague description 
for my patients? Those rare clinicians 
diligent enough to track down reference 
23 would find a fuller, but still insufficient, 
description.2 It still misses so many details 
that I (or a dietitian) would need that I 
don’t know how to replicate it. But there is 
sufficient detail to show that this form of salt 
reduction is probably impractical in primary 
care.
The accompanying editor’s choice 
suggests, “You might try talking salt in your 
next consultation,”3 but that does not seem 
viable on the basis of either this paper or the 
previous publications. That is a pity. As a 
fan of non-drug interventions, I’d like to be 
able to share them with my patients. But so 
often the description of what clinicians and 
patients need to do is so woefully inadequate 
that it is unusable. If authors are interested 
in uptake, they need to make interventions 
practical and provide sufficient details 
and materials. In the internet world, space 
limitations are no longer an excuse.
Paul P Glasziou professor of evidence based medicine, 
University of oxford, oxford oX3 8AY 
paul.glasziou@dphpc.ox.ac.uk
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Health protection requires 
legislation
Glasziou (previous letter) pleads for a 
description of what clinicians and patients 
need to do. It is not simply about adding salt 
at the dinner table but about understanding 
the considerable role that players such as 
the food industry play in public health.1 
Health protection through national fiscal 
and legislative policies should have a higher 
priority than health promotion interventions 
applied to general, primary care, and 
workforce populations.
The high risk strategy, the traditional 
medical approach to prevention, identifies 
individuals at high risk of subsequent 
cardiovascular disease events who are then 
offered behavioural or pharmacological 
interventions. In contrast, the population 
strategy seeks to control the determinants of 
incidence in the population as a whole.2
Public health policies need to take into 
account the role that agriculture, trade, 
education, the physical environment, 
town planning, and transport have on 
cardiovascular disease aetiology. Political 
action is needed to change urban planning, 
education, and policies on the agriculture, 
food, and tobacco industries.3 Until 
then, interventions such as salt reduction 
campaigns and pleading to patients to throw 
away the salt cellar in afternoon surgery 
will make little difference to population salt 
levels.
M Justin S Zaman clinical research fellow in epidemiology, 
University college london, london Wc1e 6Bt 
j.zaman@ucl.ac.uk
Competing interests: None declared.
1	 	 Cappuccio	FP.	Salt	and	cardiovascular	disease.	BMJ	
2007;334:859-60.	(28	April.)
2	 	 Rose	G.	Sick	individuals	and	sick	populations.	Int J 
Epidemiol	1985;14:32-8.
3	 	 Pekka	P,	Pirjo	P,	Ulla	U.	Influencing	public	nutrition	for	
non-communicable	disease	prevention:	from	community	
intervention	to	national	programme—experiences	from	
Finland.	Public Health Nutr 2002;5:245-51.
local councils and health
Public health must be taken 
more seriously
Blackman discusses the benefits of local 
councils taking responsibility for health.1 
I see the most effective way to reduce the 
increase in type 2 diabetes is by encouraging 
exercise, and there is no better way than to 
encourage walking and cycling. I therefore 
sit with the two public health physicians on 
our council’s children’s health and obesity 
task force, which has asked for slower speeds 
across the city and cycling training.
But these and all other large scale, slow 
speed, or pro-cycling measures have been 
rejected by other committees in the council. 
The transportation department sees its role 
as preventing traffic jams and accidents and 
helping industry (and accident rates have 
dropped at the same time as cycling and 
walking rates have fallen). And government 
policies support this.
The planning department approves large 
hypermarkets with masses of car parking, 
and large entertainment complexes, which 
in practice cannot be reached by walking, 
while allowing many smaller green spaces in 
the city that are used for improvised sport to 
be developed into housing.
Our council leader has adopted 
government policy. Local and national 
leaders have to take public health and 
environmental issues a lot more seriously if 
councils are to act effectively.
David J Kinshuck associate specialist, ophthalmology, 
Good Hope Hospital, sutton coldfield, Birmingham B75 7RR 
davidkinshuck@blueyonder.co.uk
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Pneumonia from ventilation
oral decontamination treats the 
symptom, not the cause
Oral antiseptics, like semirecumbent 
positioning and care of the ventilator circuit, 
merely address the symptom and not the 
cause of ventilator associated pneumonia 
(VAP).1
The pivotal step in the pathogenesis of 
most cases is aspiration of secretions past the 
letters
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cuff of the tracheal tube.2 Aspiration occurs 
because of a design defect in almost all cuffs 
currently available, with leakage along folds 
in the cuff wall. 
Manufacturers are now improving the 
design of tracheal tubes, ensuring maximal 
cuff performance and incorporating 
subglottic secretion drainage ports and 
antibacterial/non-stick linings. Simply 
preventing aspiration by cuff improvements 
may have a substantial impact on VAP and 
reduce the requirement for topical antiseptics 
or antibiotics.3 4
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delirium in older PeoPle
Approach is now screening, 
prevention, and recognition
The approach to delirium has shifted from 
ad hoc treatment to systematic screening and 
prevention.1 Management may be improved 
with primary prevention, early detection, 
and prompt management.
Preoperative cognitive impairment, 
as measured by the mini mental state 
examination or the clock drawing test, is 
an important predictor for postoperative 
delirium. Most elderly patients developing 
postoperative delirium after hip surgery 
have early prodromal symptoms. Low dose 
prophylactic haloperidol can reduce the 
incidence.2 Niam et al showed that methods 
proved to prevent delirium can be useful in 
routine clinical practice.3
In a large retrospective study only 4% 
of patients had a recorded diagnosis of 
delirium, yet an episode may occur in up to 
56% of hospitalised older people.4 The poor 
understanding of delirium by staff stems 
from a historically low educational emphasis 
in medical and nursing schools. Increasing 
doctors’ and nurses’ awareness can be 
achieved through a brief and inexpensive 
educational programme, which significantly 
decreases the prevalence of delirium among 
older inpatients, increases recognition of 
cases, and can be easily rolled out across 
hospital units caring for older people.5
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Delirium should be included in 
guidelines and curriculums
One critical factor in the underdiagnosis and 
undertreatment of delirium in the United 
Kingdom is likely to be its unsatisfactory 
coverage in core guidelines and curriculums.1
Delirium is not mentioned in the draft 
guideline on acutely ill patients in hospital 
from the National Institute for Health and 
Clinical Excellence (NICE).2 Delirium is also 
absent from the Joint Committee of Higher 
Medical Training curriculums for general 
internal medicine and acute medicine.3 4 
“Acute confusional states” are mentioned 
in the latter, but only in the context of 
minimising distress. In the curriculum from 
the Royal Colleges of Physicians the sole 
reference to delirium is in the section on 
aggressive/disturbed behaviour,5 although 
only a few patients with delirium display 
aggression. “Acute confusion” appears in 
the top 20 presentations and the section on 
medicine in the elderly but with no mention 
of delirium.
Care of patients would be greatly 
facilitated if delirium were covered 
adequately in core guidelines and 
curriculums. Consistent use of the term 
delirium and not its multiple, ill defined 
synonyms would reduce the terminological 
chaos and diagnostic imprecision which 
partly underpin the poor rates of recognition.
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drug cost initiative
link cost to clinical outcome
The laudable UK initiative to drive the costs 
of drugs down to affordable levels assumes 
that there is consistency in drug pricing 
between producer and recipient countries 
and that price is a barrier to use.1
When generics are included in pricing 
studies and compared with the price per 
gram of active ingredient, Japan and 
Switzerland are more expensive than the 
United States. When price per standard 
unit (a rough measure of dose, which differs 
across countries) is compared, Canada, 
Germany, Switzerland, and Sweden are 
more expensive than the US. And many 
governments subsidise research and 
development of their pharmaceutical and 
vaccine industries, making international 
comparisons difficult.2
Other factors contribute to a drug’s  
price when it finally reaches a patient.  
Some governments procure medicines 
efficiently but charge much higher prices  
to patients.3
Yet the problem remains more profound 
than simply a matter of prices: the fragility 
of health systems. The UK would help the 
developing world more by disseminating 
best practices for disease management 
through the principle of rational choices 
between therapeutic alternatives which 
promise the most advantageous economic 
value relative to clinical outcome.
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